Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1614 1615 1616 3785
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18798864 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Non-Final OA | Entera Bio Ltd. |
| 19540268 | OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE | Final Rejection | NOVALIQ GMBH |
| 19436348 | COMPOSITIONS COMPRISING AN ACTIVE INGREDIENT MIXTURE COMPRISING SILICON AND BIOTIN AND METHODS OF USE | Final Rejection | Nutrition21, LLC |
| 18841884 | COMPOSITIONS COMPRISING AN ACTIVE INGREDIENT MIXTURE COMPRISING SILICON AND BIOTIN AND METHODS OF USE | Non-Final OA | Nutrition21, LLC |
| 18224561 | NANOFIBER SHEET FOR HEALING TEAR OF ROTATOR CUFF CONTAINING RECOMBINANT PARATHYROID HORMONE AND METHOD FOR MANUFACTURING THE SAME | Non-Final OA | Pusan National University Industry-University Cooperation Foundation |
| 18756678 | COACERVATE CLEANSING COMPOSITION WITH ACNE TREATMENT ACTIVE | Non-Final OA | L'OREAL |
| 18543597 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND ACTIVE AGENT | Final Rejection | L'OREAL |
| 18549841 | PROCESS FOR REMOVING THE COLOUR FROM PREVIOUSLY COLOURED HAIR KERATIN FIBERS | Non-Final OA | L'Oreal |
| 18265749 | USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES | Non-Final OA | L'Oreal |
| 18726314 | USE OF INHALED NITRIC OXIDE (INO) FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH SARCOIDOSIS (PH-SARC) | Non-Final OA | Mallinckrodt Pharmaceuticals Ireland Limited |
| 18422810 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | Final Rejection | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy